The highlights from the April Board Meeting are now available.
Highlights from this meeting include amendments to committee member terms of office, drug scheduling amendment of Esomeprazole, Controlled Prescription Program update, PODSA modernization phase 2 update, UBC Entry-to-Practice Doctor of Pharmacy Program, and more.
The highlights from the February Board Meeting are now available.
Highlights from this meeting include the Patient Relations Program Standard, amalgamation of committees, PODSA ownership update, guest presentations from the Therapeutics Initiative and BC Drug and Poison Information Centre, injection authority and more.
A new Opioid Agonist Treatment Compliance and Management Program (OAT-CAMPP) for community pharmacy has been developed aimed at reducing stigma and expanding pharmacists’ knowledge about methadone, buprenorphine/naloxone and slow-release oral morphine.